Form 4 for GPUS Hyperscale Data, Inc.
Accepted 2024-09-12 00:00:00 ET · period of report 2024-09-10 · accession 0001214659-24-016397 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-12 | 2024-09-11 | GPUS | AULT MILTON C III | Executive COB, Dir, 10% | P - Purchase | $13.69 | +6 | 116 | +5% | +$82.14 | |
| MI | 2024-09-12 | 2024-09-10+ | GPUS | AULT MILTON C III | Executive COB, Dir, 10% | P - Purchase | $0.2156 | +22.5K | 107.7K | +26% | +$4,850 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | 13% Series D Cumulative Redeemable Perpetual Preferred Stock | 2024-09-11 | P | A | 6 | $13.69 | 116 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-11 | P | A | 10,000 | $0.21 | 117,729 | I By Ault & Company, Inc. | — | — | (F2) Milton C. Ault, III, is the Chief Executive Officer of Ault & Company, Inc. ("Ault & Co.") and is deemed to beneficially own the shares held by Ault & Co. |
| 3 | Common | Common Stock | 2024-09-10 | P | A | 12,500 | $0.22 | 107,729 | I By Ault & Company, Inc. | — | — | (F1) The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $0.2194. The range of purchase prices on the transaction date was $0.219 to $0.22 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price. (F2) Milton C. Ault, III, is the Chief Executive Officer of Ault & Company, Inc. ("Ault & Co.") and is deemed to beneficially own the shares held by Ault & Co. |